Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 349Neoplasms 315Carcinoma, Non-Small-Cell Lung 277Prostatic Neoplasms 221Colorectal Neoplasms 208Lung Neoplasms 177Multiple Myeloma 149Ovarian Neoplasms 136Pancreatic Neoplasms 130Neoplasm Metastasis 123Leukemia, Myeloid, Acute 121Melanoma 104Squamous Cell Carcinoma of Head and Neck 90Recurrence 84Lymphoma 84Carcinoma, Renal Cell 84Lymphoma, Non-Hodgkin 82Endometrial Neoplasms 82Stomach Neoplasms 80Brain Neoplasms 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Carcinoma, Hepatocellular 77Head and Neck Neoplasms 71Glioma 70Glioblastoma 70Uterine Cervical Neoplasms 67Urinary Bladder Neoplasms 65Leukemia, Lymphocytic, Chronic, B-Cell 65Sarcoma 63Hematologic Neoplasms 62

Interventions

irinotecan sucrosofate 1Folfox protocol 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Rectal Cancer × 30 days × Clear all
NCT03781323 2026-06-04

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

University of Rochester

Phase 2 Active not recruiting
12 enrolled 9 charts
Gastrointestinal

Advanced Rectal Cancer

NCT07281157 2026-06-03

Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡